“A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris”, J of Skin, vol. 4, no. 1, p. S26, Jan. 2020, Accessed: Apr. 19, 2026. [Online]. Available: https://skin.dermsquared.com/skin/article/view/806